AT Hirsch, ZJ Haskal, NR Hertzer, CW Bakal… - Journal of the American …, 2006 - jacc.org
These guidelines address the diagnosis and management of atherosclerotic, aneurysmal, and thromboembolic peripheral arterial diseases (PADs). The clinical manifestations of PAD …
GP Clagett, M Sobel, MR Jackson, GYH Lip… - Chest, 2004 - Elsevier
This chapter about antithrombotic therapy for peripheral arterial occlusive disease is part of the seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy: Evidence …
G Dhaliwal, D Mukherjee - International Journal of Angiology, 2007 - thieme-connect.com
Lower extremity peripheral arterial disease (PAD) affects approximately 10% of the American population, with 30% to 40% of these patients presenting with claudication …
This chapter is devoted to antithrombotic therapy for peripheral artery occlusive disease as part of the American College of Chest Physicians Evidence-Based Clinical Practice …
MA Lambert, JJF Belch - Journal of internal medicine, 2013 - Wiley Online Library
Critical limb ischaemia (CLI) is a severe form of peripheral arterial disease (PAD). CLI often causes disabling symptoms of pain and can lead to loss of the affected limb. It is also …
S Coccheri, G Scondotto, G Agnelli… - European heart …, 2002 - academic.oup.com
Aims Patients with peripheral arterial obstructive disease require treatment to prevent major cardiovascular events and to relieve intermittent claudication. The walking performance of …
JM Dogné, X Leval, J Hanson… - Current medicinal …, 2004 - ingentaconnect.com
The pathogenesis of numerous cardiovascular, pulmonary, inflammatory, and thromboembolic diseases can be related to arachidonic acid (AA) metabolites. One of these …
GK Ambler, CA Waldron, UB Contractor… - Journal of British …, 2020 - academic.oup.com
Background The literature on antiplatelet therapy for peripheral artery disease has historically been summarized inconsistently, leading to conflict between international …